Lindbrook Capital, LLC Spring Works Therapeutics, Inc. Transaction History
Lindbrook Capital, LLC
- $1.18 Billion
- Q3 2024
A detailed history of Lindbrook Capital, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 106 shares of SWTX stock, worth $3,863. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106
Previous 92
15.22%
Holding current value
$3,863
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding SWTX
# of Institutions
238Shares Held
69.8MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$245 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$205 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$140 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$128 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$125 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.27B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...